desipramine has been researched along with norfluoxetine in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 7 (46.67) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Sen, S; Sinha, N | 1 |
Bergstrom, RF; Lemberger, L; Peyton, AL | 1 |
Fuller, RW; Snoddy, HD | 1 |
Downs, AD; Downs, JM | 1 |
Coutaux, AF; Mooney, JJ; Wirth, DF | 1 |
Baker, GB; Goodnough, DB | 1 |
el-Yazigi, A; Raines, DA | 1 |
Baker, GB; Coutts, RT; Goodnough, DB | 1 |
Hashimoto, K; Minabe, Y; Narita, N; Tomitaka, S | 1 |
Abdel-Razaq, W; Bates, TE; Kendall, DA; Richards, JK | 1 |
Abdel-Razaq, W; Bates, TE; Kendall, DA | 2 |
Allen, KE; Babu, KN; Hanson, KL; Kunze, KL; Nelson, WL; VandenBrink, BM | 1 |
Benham, RS; Engin, E; Hewage, NB; Rudolph, U; Suckow, RF | 1 |
15 other study(ies) available for desipramine and norfluoxetine
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
Topics: Adult; Desipramine; Drug Evaluation; Drug Interactions; Fluoxetine; Humans; Imipramine; Male; Middle Aged | 1992 |
Role of norfluoxetine in the inhibition of desipramine metabolism and in the inhibition of serotonin uptake after fluoxetine administration to rats.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Depression, Chemical; Desipramine; Fluoxetine; Hydroxyindoleacetic Acid; Liver; Male; Rats; Rats, Inbred Strains | 1991 |
Effect of fluoxetine on metabolism of tricyclic antidepressants in the lungs.
Topics: Desipramine; Female; Fluoxetine; Humans; Liver; Lung | 1989 |
Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.
Topics: 1-Naphthylamine; Animals; Chloroquine; Desipramine; Drug Resistance; Drug Synergism; Fluoxetine; Neurotransmitter Uptake Inhibitors; Plasmodium falciparum; Sertraline | 1994 |
5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination.
Topics: Animals; Brain; Cerebral Cortex; Desipramine; Drug Combinations; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonin; Time Factors | 1994 |
Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, nortriptyline, and desipramine in plasma.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Chromatography, Liquid; Desipramine; Fluoxetine; Humans; Imipramine; Indicators and Reagents; Nortriptyline; Spectrophotometry, Ultraviolet | 1993 |
Simultaneous quantification of fluoxetine, norfluoxetine, and desipramine using gas chromatography with nitrogen-phosphorus detection.
Topics: Animals; Antidepressive Agents; Brain Chemistry; Chromatography, Gas; Desipramine; Drug Interactions; Fluoxetine; Liver; Male; Mass Spectrometry; Nitrogen; Phosphorus; Rats; Rats, Sprague-Dawley; Reference Standards; Tissue Distribution | 1995 |
Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Desipramine; Fluoxetine; Imipramine; Male; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Selective Serotonin Reuptake Inhibitors; Stereoisomerism | 1996 |
The effects of desmethylimipramine on cyclic AMP-stimulated gene transcription in a model cell system.
Topics: Alkaline Phosphatase; Animals; Antidepressive Agents, Tricyclic; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; GPI-Linked Proteins; Isoenzymes; Phosphorylation; Transcription, Genetic | 2005 |
The effects of antidepressants on cyclic AMP-response element-driven gene transcription in a model cell system.
Topics: Alkaline Phosphatase; Animals; Antidepressive Agents, Tricyclic; Blotting, Western; CHO Cells; Clomipramine; Cricetinae; Cricetulus; Cyclic AMP Response Element-Binding Protein; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Genes, Reporter; Humans; Receptors, Adrenergic, beta-2; Thiazepines; Time Factors; Transcription, Genetic | 2007 |
Sequential metabolism of secondary alkyl amines to metabolic-intermediate complexes: opposing roles for the secondary hydroxylamine and primary amine metabolites of desipramine, (s)-fluoxetine, and N-desmethyldiltiazem.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Desipramine; Diltiazem; Fluoxetine; Humans; Hydroxylamine; Hydroxylamines; Hydroxylation; Imipramine; Microsomes, Liver; Oxidoreductases, N-Demethylating; Steroid 16-alpha-Hydroxylase | 2010 |
The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria.
Topics: Animals; Antidepressive Agents; CHO Cells; Clomipramine; Cricetinae; Cricetulus; Desipramine; Electron Transport Chain Complex Proteins; Fluoxetine; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Oxygen Consumption; Rats; Rats, Wistar; Thiazepines | 2011 |
Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABA
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Anxiety; Depression; Desipramine; Dose-Response Relationship, Drug; Feeding Behavior; Fluoxetine; Male; Mice, 129 Strain; Mice, Knockout; Motor Activity; Phenotype; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors | 2017 |